Cargando…

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions

Host innate immune response follows severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and it is the driver of the acute respiratory distress syndrome (ARDS) amongst other inflammatory end-organ morbidities. Such life-threatening coronavirus disease 2019 (COVID-19) is heralded b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelmoaty, Mai M., Yeapuri, Pravin, Machhi, Jatin, Olson, Katherine E., Shahjin, Farah, Kumar, Vikas, Zhou, You, Liang, Jingjing, Pandey, Kabita, Acharya, Arpan, Byrareddy, Siddappa N., Mosley, R. Lee, Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521106/ https://www.ncbi.nlm.nih.gov/pubmed/34671355 http://dx.doi.org/10.3389/fimmu.2021.741502

Ejemplares similares

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

Immune senescence in aged APP/PS1 mice
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

The 2022 outbreak and the pathobiology of the monkeypox virus
por: Kumar, Narendra, et al.
Publicado: (2022)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Machhi, Jatin, et al.
Publicado: (2021)

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
por: Machhi, Jatin, et al.
Publicado: (2020)

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

Immunotherapy for Parkinson’s disease
por: Schwab, Aaron D., et al.
Publicado: (2020)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
por: Machhi, Jatin, et al.
Publicado: (2021)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
por: Zagorski, Karen, et al.
Publicado: (2022)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease
por: Mosley, R. Lee, et al.
Publicado: (2019)

Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV Infection
por: Olwenyi, Omalla A., et al.
Publicado: (2021)

Mental Health Issues During and After COVID-19 Vaccine Era
por: Pandey, Kabita, et al.
Publicado: (2021)

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
por: Acharya, Arpan, et al.
Publicado: (2022)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

Modular nanoarray vaccine for SARS-CoV-2
por: Zagorski, Karen, et al.
Publicado: (2022)

Chronic Morphine Administration Differentially Modulates Viral Reservoirs in a Simian Immunodeficiency Virus SIVmac251-Infected Rhesus Macaque Model
por: Acharya, Arpan, et al.
Publicado: (2021)

Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States
por: Singu, Sravani, et al.
Publicado: (2020)

Clinical biomarkers for Lewy body diseases
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype
por: Devadoss, Dinesh, et al.
Publicado: (2022)

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
por: Olson, Katherine E., et al.
Publicado: (2021)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques
por: Olwenyi, Omalla A., et al.
Publicado: (2022)

Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
por: Thurman, Michellie, et al.
Publicado: (2020)

Molecular Aspects of COVID-19 Differential Pathogenesis
por: Rothan, Hussin A., et al.
Publicado: (2020)

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
por: Leinen, Zach J., et al.
Publicado: (2023)

Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
por: Johnson, Samuel D, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection
por: Vann, Kendra R., et al.
Publicado: (2022)

Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
por: Zandian, Mohamad, et al.
Publicado: (2022)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

Safety and Immunological Evaluation of Interleukin-21 Plus Anti-α4β7 mAb Combination Therapy in Rhesus Macaques
por: Pino, Maria, et al.
Publicado: (2020)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4ahqhqtcg5gtu9e582khdtilc